↓ Skip to main content

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies

Overview of attention for article published in Journal of Hematology & Oncology, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
Published in
Journal of Hematology & Oncology, January 2022
DOI 10.1186/s13045-022-01228-0
Pubmed ID
Authors

Antonella Padella, Andrea Ghelli Luserna Di Rorà, Giovanni Marconi, Martina Ghetti, Giovanni Martinelli, Giorgia Simonetti

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 74 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 16%
Student > Ph. D. Student 11 15%
Student > Bachelor 5 7%
Unspecified 4 5%
Professor 2 3%
Other 5 7%
Unknown 35 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 16 22%
Unspecified 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Medicine and Dentistry 4 5%
Immunology and Microbiology 2 3%
Other 5 7%
Unknown 38 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2022.
All research outputs
#13,643,324
of 23,138,859 outputs
Outputs from Journal of Hematology & Oncology
#640
of 1,202 outputs
Outputs of similar age
#214,493
of 503,752 outputs
Outputs of similar age from Journal of Hematology & Oncology
#12
of 19 outputs
Altmetric has tracked 23,138,859 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,202 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 503,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.